Olistico Wealth’s AbbVie ABBV Stock Holding History

Olistico Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$493K	Buy	1,885 +1	+0.1%	+$256	0.21%	68
2026 Q2	$474K	Buy	1,884 +925	+96%	+$199K	0.2%	70
2026 Q1	$209K	Buy	959 +132	+16%	+$29.3K	0.1%	97
2025 Q4	$189K	Buy	+827	New	+$188K	0.09%	96
2025 Q3	–	Sell	-849	Closed	-$158K	–	97
2025 Q2	$158K	Buy	849 +53	+7%	+$9.8K	0.09%	105
2025 Q1	$167K	Sell	796 -1	-0.1%	-$194	0.1%	107
2024 Q4	$142K	Buy	797 +1	+0.1%	+$184	0.08%	110
2024 Q3	$157K	Sell	796 -1	-0.1%	-$187	0.1%	108
2024 Q2	$137K	Buy	+797	New	+$132K	0.09%	108

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Olistico Wealth's ABBV Position: Q3 2026 in Review

Olistico Wealth increased its AbbVie (ABBV) stake by 0.05% in Q3 2026, buying an estimated $256 and bringing the position to 1,885 shares worth $493K. The position accounts for 0.21% of the portfolio, ranked #68.

Olistico Wealth first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. 1,436 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Olistico Wealth held 1,885 shares of AbbVie worth $493K as of Q3 2026.
Olistico Wealth bought 1 AbbVie share in Q3 2026, an estimated $256.
AbbVie made up 0.21% of Olistico Wealth's portfolio in Q3 2026, its #68 holding.
Olistico Wealth first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
1,436 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Olistico Wealth's 13F filing for Q3 2026, filed 5 Oct 2026.